All posts by: Michael Zand

Sanford Studying Immunotherapy Drug for Esophageal Cancer – Benzinga

Sanford Studying Immunotherapy Drug for Esophageal CancerBenzingaA clinical trial at Sanford Health is studying if an immunotherapy drug developed by Merck might be able to treat certain patients with advanced esophageal cancer. The Merck Keynote 181 t… Continue reading

Sanford Studying Immunotherapy Drug for Esophageal Cancer – Benzinga

Sanford Studying Immunotherapy Drug for Esophageal CancerBenzingaA clinical trial at Sanford Health is studying if an immunotherapy drug developed by Merck might be able to treat certain patients with advanced esophageal cancer. The Merck Keynote 181 t… Continue reading

Sanford Studying Immunotherapy Drug for Esophageal Cancer – Benzinga

Sanford Studying Immunotherapy Drug for Esophageal CancerBenzingaA clinical trial at Sanford Health is studying if an immunotherapy drug developed by Merck might be able to treat certain patients with advanced esophageal cancer. The Merck Keynote 181 t… Continue reading

On target: Researcher arms platelets to deliver cancer immunotherapy – Science Daily

Science Daily

On target: Researcher arms platelets to deliver cancer immunotherapy Science Daily To overcome these problems, Gu’s research team used immunotherapy to directly target residual tumors after a surgery or surgeries to remove the primary tumor, rather than to nonspecifically bolster the immune system. Gu’s team engineered a new method …

UH Rainbow Babies & Children’s begins first stem cell study in patients with cystic fibrosis Crain’s Cleveland Business A man from Alliance with cystic fibrosis recently became the first person in the world to receive human adult stem cells in a CF study that began last week at University Hospitals. Researchers hope the study eventually will lead to the development of a … World’s First Stem–Cell Study for Cystic FibrosisP&T Community all 2 news articles »

World’s First Stem–Cell Study for Cystic Fibrosis P&T Community A 39-year-old man with cystic fibrosis (CF) has made history by becoming the first person in the world to receive human adult stem cells in a new study that researchers hope will some day lead to the development of a therapy to reduce the inflammation … UH Rainbow Babies & Children’s begins first stem cell study in patients with cystic fibrosisCrain’s Cleveland Business all 2 news articles »

Genetic Literacy Project

Conference looks at the medical possibilies of using adult stem cells Florida Times-Union In 2014, when Springer Publications published “Stem Cells in Aesthetic Procedures,” the first book ever published on the subject, Jacksonville physician Lewis Obi contributed a chapter, “Specialized Stem Cell Fat Transfer to Face.” At places like the … Heart attack victims: Stem cell therapy offers promise | Genetic …Genetic Literacy Project Future of Global Stem Cell Assay Market 2016 – 2024Satellite PR News (press release) NEI scientists identify stem cell secretions may protect against …pharmabiz.com Australian Journal of Pharmacy (registration) (blog) –Digital Journal –Counsel & Heal all 10 news articles »

Xconomy

Investors Sour on Data Debut For Dimension’s Hemophilia Gene Therapy Xconomy Despite the early and in some cases stunning results produced by gene therapy treatments in handfuls of hemophilia patients, significant questions remain about their durability, safety, and how broadly they’ll be used if they are ultimately shown to work. Dimension Therapeutics’ gene therapy candidate for hemophilia B shows treatment benefit in early-stage study but …Seeking Alpha Dimension Therapeutics, Inc. (NASDAQ:DMTX) Files An 8-K Regulation FD DisclosureMarket Exclusive Is Dimension Therapeutics Inc (DMTX)’s Fuel Running Low? The Stock Reaches Yearly Low TodayThe Randolph Guide StreetInsider.com all 9 news articles »